Voltage-gated calcium channel and receptor-operated calcium channel (VGCC/ROCC)

Voltage-gated and receptor-operated calcium channels (VGCCs and ROCCs) are essential transmembrane proteins that facilitate the entry of calcium ions into the cytoplasm, acting as key transducers of electrical and chemical signals into intracellular responses (Catterall, 2011, Cold Spring Harb Perspect Biol). VGCCs are activated by changes in membrane potential and are categorized into high-voltage activated (L, N, P/Q, and R-types) and low-voltage activated (T-type) classes, which are fundamental to cardiac pacemaking, muscle contraction, and neurotransmission (Zamponi et al., 2015, Pharmacol Rev). ROCCs, in contrast, are gated by the binding of extracellular ligands or intracellular second messengers, such as glutamate-gated NMDA receptors or certain TRP channels, and are crucial for synaptic plasticity and sensory perception (Putney, 1994, Biol Signals). Dysfunction in these channel systems is linked to a variety of conditions, including hypertension, chronic pain, epilepsy, and cardiac arrhythmias (Striessnig et al., 2014, Channels). Pharmacological modulation of these channels is a cornerstone of modern medicine, with L-type VGCC blockers like amlodipine used for cardiovascular health and N-type blockers or NMDA antagonists used for pain and neurological management (Doering & Zamponi, 2003, J Bioenerg Biomembr). Because these channels are expressed across diverse tissues, targeting them requires high specificity to avoid systemic side effects like hypotension or impaired cardiac conduction (StatPearls, 2023, Calcium Channel Blockers).

Other names

Calcium channelsCa2+ channelsVoltage-dependent calcium channelsLigand-gated calcium channelsVoltage-operated channels (VOCs)Receptor-operated channels (ROCs)

These channels are primarily targeted by antagonists or pore blockers that inhibit the influx of calcium ions into the cytoplasm, thereby dampening downstream signaling pathways such as muscle contraction or excitatory neurotransmission (Zamponi et al., 2015, Pharmacol Rev).